XLV Healthcare SPDR June Outlook—Looking for some tactical mean-reversion performance after a brutal 15-months for the sector
The XLV has continued to deteriorate and has been a large underweight in our process since the bull market started in early 2023. However, our work also suggests that oversold defensive shares can be a good tactical add to a portfolio and that’s what XLV shares are this month. Our Elev8 Sector Model debuts with an OVERWEIGHT position in XLV of + 1.02%